Friday 6 November 2026
Export RNR’s income statement to Excel — free account
RenaissanceRe Holdings Ltd.
RNR Financial Insurance Reinsurance
RenaissanceRe Holdings Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $12.8 billion, up 9.86% from fiscal 2024.
- Revenue
- −47.1%
- EPS
- −120.7%
- Free cash flow
- −49.8%
- Total debt
- +4.60%
Quarter to September 2026, against a year earlier
349.44
4.79
−1.35%
Follow RNR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
9.11 | 5.42 | 4.94 | 4.95 |
+8 more quarters Free account |
P/S ratio |
1.33 | 1.18 | 1.09 | 1.01 | |
P/FCF ratio |
4.55 | 3.64 | 2.99 | 3.53 | |
P/Operating CF |
16.14 | 15.38 | 18.34 | 26.96 | |
P/B ratio |
1.21 | 1.18 | 1.17 | 1.20 | |
Price to Tangible BV |
1.28 | 1.25 | 1.24 | 1.27 | |
EV/Sales |
— | 1.27 | 1.16 | 1.06 | |
EV/EBITDA |
— | 3.17 | 2.84 | 3.31 | |
EV/Operating CF |
— | 3.92 | 3.17 | 3.69 | |
EV/FCF |
— | 3.92 | 3.17 | 3.69 | |
Quick Ratio |
0.47 | 0.47 | 0.47 | 0.46 | |
Current Ratio |
0.47 | 0.47 | 0.47 | 0.46 | |
Net Debt/EBITDA |
(48.15) | 0.91 | 1.38 | 0.47 | |
Debt/Assets |
4.25% | 4.22% | 4.34% | 4.33% | |
Debt/Equity |
0.21 | 0.20 | 0.20 | 0.20 | |
Asset Turnover |
0.18 | 0.20 | 0.22 | 0.25 | |
Operating CF/Net income |
(4.90) | 1.33 | 2.46 | 0.65 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(0.01) | 36.17 | 18.27 | 41.26 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.24% | 3.42% | 4.06% | 3.82% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(2.23) | (2.14) | (2.16) | (2.14) | |
Graham Number |
454.87 | 593.06 | 585.88 | 547.52 | |
Earnings Yield |
10.98% | 18.44% | 20.23% | 20.21% | |
Free Cash Flow Yield |
21.98% | 27.50% | 33.48% | 28.36% | |
Revenue per Share |
41.99 | 66.91 | 51.73 | 64.19 | |
Operating CF per Share |
19.72 | 20.60 | 16.20 | 10.43 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
19.72 | 20.60 | 16.20 | 10.43 | |
Cash per Share |
27.26 | 31.47 | 36.83 | 37.38 | |
Shareholders Equity per Share |
281.81 | 285.66 | 271.34 | 250.64 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
281.81 | 285.66 | 271.34 | 250.64 | |
Free Cash Flow |
794.50 | 852.36 | 687.57 | 482.98 | |
Working Capital |
(16,702.09) | (17,193.15) | (17,069.30) | (16,579.19) | |
Net Current Asset Value |
(28,537.04) | (28,067.36) | (27,275.01) | (27,899.88) | |
EV/EBIT |
— | 3.12 | 2.81 | 3.29 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
4.42 | 2.97 | 2.72 | 3.24 | |
| Other line items | |||||
Average Receivables |
13,665.13 | 14,554.62 | 13,878.24 | 12,656.15 | |
Average Payables |
32,023.14 | 33,012.04 | 32,355.89 | 30,464.65 | |
Average Assets |
54,664.64 | 54,961.57 | 53,675.87 | 52,253.97 | |
Average Common Equity |
10,677.46 | 10,559.95 | 10,181.37 | 10,341.34 |
Columns are period end dates · fundamentals updated 5 Nov 2026